<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04700111</url>
  </required_header>
  <id_info>
    <org_study_id>CPRO-2011-001</org_study_id>
    <nct_id>NCT04700111</nct_id>
  </id_info>
  <brief_title>Lag of Accommodation Involving Young Myopes and Patterned Spectacle Lenses</brief_title>
  <acronym>ASH</acronym>
  <official_title>Lag of Accommodation Involving Young Myopes and Patterned Spectacle Lenses</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>SightGlass Vision, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Waterloo</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>SightGlass Vision, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>Yes</is_unapproved_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of the study is to measure the difference in the lag of accommodation of two&#xD;
      iterations of patterned spectacle lenses compared to a control spectacle. The Pattern 1&#xD;
      iteration induces less reduction in contrast than Pattern 2.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">November 1, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 30, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Best vision sphere</measure>
    <time_frame>80 minutes</time_frame>
    <description>1) Autorefractor best vision sphere measured at distance and at 40cm with each pair of treatment spectacles</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">75</enrollment>
  <condition>Myopia, Myopia Progression, Lag of Accommodation, Hyperopic Retinal Blur, Reduction in Contrast</condition>
  <arm_group>
    <arm_group_label>Pattern 1 spectacle lens</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Pattern 1 spectacle lens or treatment 1</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Pattern 2 spectacle lens</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Pattern 1 spectacle lens or treatment 2</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control lens</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Comparator lens or control arm</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>DOT Pattern 1</intervention_name>
    <description>DOT Pattern 1 Spectacle Lens</description>
    <arm_group_label>Pattern 1 spectacle lens</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>DOT Pattern 2</intervention_name>
    <description>DOT Pattern 2 Spectacle Lens</description>
    <arm_group_label>Pattern 2 spectacle lens</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Control lens</intervention_name>
    <description>Control lens</description>
    <arm_group_label>Control lens</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        A person is eligible for inclusion in the study if he/she:&#xD;
&#xD;
          1. Age 6-18 years of age, with a maximum of 6 of the first 25 completed participants&#xD;
             being older than 14 years of age.&#xD;
&#xD;
          2. Is able to read (or be read to), understand and sign the assent document if under 17&#xD;
             years old or is able to read, understand and sign the consent document if aged 17 or&#xD;
             18 years.&#xD;
&#xD;
          3. Is under 17 years old and is accompanied by a parent or legal guardian who is able to&#xD;
             read, understand and sign the parental information and permission document.&#xD;
&#xD;
          4. Currently wearing spectacles, contact lenses to correct myopia or is wearing no&#xD;
             correction due to low prescription.&#xD;
&#xD;
          5. Should be myopic by non-cycloplegic auto-refraction.&#xD;
&#xD;
          6. Should have minus power in both principal meridians in non-cycloplegia&#xD;
             auto-refraction.&#xD;
&#xD;
          7. For non-CL wearers, SER by auto-refraction should be between -0.25 DS and -0.75 DS in&#xD;
             both eyes (sphere power no less than -0.25 DS and cylindrical power no more than -1.00&#xD;
             DC).&#xD;
&#xD;
          8. For CL wearers, over-refraction SER by auto-refraction not greater than -0.75 DS in&#xD;
             either eye;&#xD;
&#xD;
          9. Is willing and able to follow instructions.&#xD;
&#xD;
        A person will be excluded from the study if he/she:&#xD;
&#xD;
          1. Is participating in any concurrent clinical or research study.&#xD;
&#xD;
          2. Is currently not wearing and has no history of wearing a correction for myopia&#xD;
             control.&#xD;
&#xD;
          3. Has amblyopia in either eye or known to have any other binocular vision disorder, such&#xD;
             as accommodative insufficiency.&#xD;
&#xD;
          4. Has any known active ocular disease and/or infection.&#xD;
&#xD;
          5. Has a systemic condition that in the opinion of the investigator may affect a study&#xD;
             outcome variable. Examples include diabetes mellitus, hyperthyroidism.&#xD;
&#xD;
          6. Is using any systemic or topical medications that in the opinion of the investigator&#xD;
             may affect a study outcome variable. Examples include Atropine eye drops.&#xD;
&#xD;
          7. Has undergone strabismus surgery, refractive error surgery or intraocular surgery.&#xD;
&#xD;
          8. Is a child of a member of the study team.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Years</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Jill Woods, MCOptom</last_name>
    <phone>1-519-888-4567</phone>
    <phone_ext>36743</phone_ext>
    <email>jwoods@uwaterloo.ca</email>
  </overall_contact>
  <location>
    <facility>
      <name>Centre for Ocular Research and Education</name>
      <address>
        <city>Waterloo</city>
        <state>Ontario</state>
        <zip>N2L 3G1</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lyndon Jones, PhD, FCOptom</last_name>
      <phone>5198884567</phone>
      <phone_ext>36743</phone_ext>
    </contact>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>January 6, 2021</study_first_submitted>
  <study_first_submitted_qc>January 6, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 7, 2021</study_first_posted>
  <last_update_submitted>September 9, 2021</last_update_submitted>
  <last_update_submitted_qc>September 9, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 13, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Myopia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

